Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1482 Articles

Jon C. Ogg | Mar 20, 2019 at 4:25 PM EDT

Why Pfizer Is Getting Deeper Into Gene Therapy

Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing…

Chris Lange | Mar 20, 2019 at 11:29 AM EDT

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Pfizer is looking to collaborate with Vivet on the development of its proprietary treatment for Wilson disease.

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 12, 2019 at 7:00 AM EDT

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the February 15 and February 28…

Chris Lange | Feb 28, 2019 at 8:30 AM EST

Major Pharma Sees Tremendous Rise in Short Interest

The February 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Feb 28, 2019 at 6:35 AM EST

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the January 31 and February 15…

Jon C. Ogg | Feb 25, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Allscripts, AmeriGas, CVS, IMAX, Kraft Heinz, Marathon Oil, Microsoft, Pfizer and Many More

The top analyst upgrades, downgrades and initiations seen for Monday included Allscripts Healthcare Solutions, AmeriGas Partners, CVS Health, IMAX, Kraft…

Chris Lange | Feb 12, 2019 at 9:35 AM EST

Major Pharma Scares Off Short Sellers

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 11, 2019 at 7:10 AM EST

The 15 Best Dividend Stocks for Retirees to Own

There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those…

Lee Jackson | Feb 5, 2019 at 7:20 AM EST

Why It Is Time to Sell the Rally and Buy Safe Dividend Stocks

These four solid companies have released good earnings and pay consistent and healthy dividends. All make more sense going forward…

Jon C. Ogg | Jan 31, 2019 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell,…

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

Chris Lange | Jan 29, 2019 at 9:25 AM EST

Why Pfizer Fell Short in Q4

Pfizer released better-than-expected fourth-quarter financial results and guidance before the markets opened on Tuesday.

Chris Lange | Jan 28, 2019 at 10:15 AM EST

What to Expect When Pfizer Reports Tuesday

Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest…

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 29 30 31 32 33 … 99

Pfizer : PFE

All Pfizer Articles

Why Pfizer Is Getting Deeper Into Gene Therapy

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Big Pharma Short Interest Backs Off, With One Huge Exception

The 6 Most Shorted NYSE Stocks

Major Pharma Sees Tremendous Rise in Short Interest

The 6 Most Shorted NYSE Stocks

Top Analyst Upgrades and Downgrades: Allscripts, AmeriGas, CVS, IMAX, Kraft Heinz, Marathon Oil, Microsoft, Pfizer and Many More

Major Pharma Scares Off Short Sellers

The 15 Best Dividend Stocks for Retirees to Own

Why It Is Time to Sell the Rally and Buy Safe Dividend Stocks

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Why Pfizer Fell Short in Q4

What to Expect When Pfizer Reports Tuesday

Short Interest Spikes in a Couple Major Pharma Stocks

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Pfizer : PFE

All Pfizer Articles

Why Pfizer Is Getting Deeper Into Gene Therapy

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Big Pharma Short Interest Backs Off, With One Huge Exception

The 6 Most Shorted NYSE Stocks

Major Pharma Sees Tremendous Rise in Short Interest

The 6 Most Shorted NYSE Stocks

Top Analyst Upgrades and Downgrades: Allscripts, AmeriGas, CVS, IMAX, Kraft Heinz, Marathon Oil, Microsoft, Pfizer and Many More

Major Pharma Scares Off Short Sellers

The 15 Best Dividend Stocks for Retirees to Own

Why It Is Time to Sell the Rally and Buy Safe Dividend Stocks

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Why Pfizer Fell Short in Q4

What to Expect When Pfizer Reports Tuesday

Short Interest Spikes in a Couple Major Pharma Stocks

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Featured Reads

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73